SWEDEPAD 2: time to rethink your practice?

The SWEDEPAD 2 trial has reignited the debate on the safety and efficacy of paclitaxel-coated devices in claudicant patients.

Before our upcoming PVI webinar on October 21, we invite you to share your perspective.
Has SWEDEPAD 2 influenced your practice... or confirmed your previous choices?

Vote now, and find out what your peers think, live on October 21!